MarketWatch
4 Aug 2008
SAN DIEGO, Aug 04, 2008 (BUSINESS WIRE) -- Cytori Therapeutics entered into a Binding Letter of Intent to complete a StemSource(R) Cell Bank sales agreement with Astrea International. Astrea has committed to purchase one StemSource Cell Bank for Singapore following receipt of regulatory clearance in Singapore on a pending application on the use of the Celution(R) System for tissue banking. In addition, Astrea has obtained rights from Cytori to commercialize additional StemSource Cell Banks in Malaysia and Brunei.
>>>> More
